About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (11)
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
9
As Collaborator
2
Total Enrollment
2,748
By Phase
PHASE2: 5PHASE1/PHASE2: 2PHASE1: 1PHASE3: 3
By Status
COMPLETED: 9TERMINATED: 2
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT03875859Collaborator
Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)
PHASE2Terminated
4 participants
Started: Dec 12, 2019 · Completed: Jan 30, 2021
NCT03781934Lead Sponsor
A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations
PHASE1/PHASE2Completed
53 participants
Started: Sep 5, 2018 · Completed: Jun 16, 2025
NCT03180528Collaborator
Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer
PHASE2Completed
30 participants
Started: Jul 7, 2018 · Completed: Dec 31, 2020
NCT03443453Lead Sponsor
A Bioavailability Study of MIV-711 Oral Formulations in Healthy Volunteers
PHASE1Completed
18 participants
Started: Jan 19, 2018 · Completed: Feb 17, 2018
NCT02587962Lead Sponsor
Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors
PHASE1/PHASE2Terminated
34 participants
Started: Aug 4, 2017 · Completed: Feb 17, 2020
Locations (1)
Headquarters
Huddinge, Sweden
Map
Loading map...